Form 4: Macrogenics Director Karen Jean Ferrante Reports Acquisition of Stock Options and Restricted Stock Units

Director Karen Jean Ferrante reports the acquisition of stock options and restricted stock units in Macrogenics Inc.

Summary

• Karen Jean Ferrante, a director at Macrogenics Inc. (MGNX), filed a Form 4 on May 23, 2024, reporting transactions that occurred on May 21, 2024.
• Ferrante acquired 6,500 Restricted Stock Units (RSUs) and 16,500 stock options.
• The RSUs vest one year after the grant date or the day before the next annual meeting, whichever is earlier.
• The stock options vest in monthly increments over one year from the grant date and expire in 10 years.
• Following the reported transactions, Ferrante directly owns 6,500 RSUs and 16,500 stock options.

Sentiment

Score: 6

Explanation: Neutral sentiment. The filing is a standard disclosure of stock options and RSU grants to a director. It doesn't inherently indicate positive or negative sentiment, but rather reflects standard compensation practices.

Positives

• The acquisition of stock options and RSUs by a director could be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The vesting schedules of the RSUs and stock options suggest a long-term commitment by the director to the company's success.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding insider transactions. These filings are closely monitored by investors to gauge management's sentiment and alignment with shareholder interests.

Stakeholder Impact

• The acquisition of stock options and RSUs by a director can align the director's interests with those of the shareholders, potentially encouraging decisions that benefit the company's long-term value.

Key Dates